Show simple item record

dc.contributor.advisorAbell, Troy
dc.contributor.authorCooper, Jacob
dc.contributor.otherBaylor University.en_US
dc.contributor.otherLisa Bakeren_US
dc.contributor.otherMichael Carmichaelen_US
dc.date.accessioned2012-05-07T21:48:59Z
dc.date.available2012-05-07T21:48:59Z
dc.date.copyright2012
dc.date.issued2012-05-07
dc.identifier.urihttp://hdl.handle.net/2104/8392
dc.description.abstractCoronary artery bypass grafting (CABG) surgery is one of the most common operations performed in the United States. Despite the frequency of this operation, however, it is estimated that surgical site infections (SSIs) occur with a cumulative incidence between 0.5%-7% among CABG patients. In a time of increasing pressure for health care to improve in quality, hospitals must prevent such infections or risk being required to pay for the expenses incurred to treat those infections that arise. Autologous Platelet Gel (APG) has presented itself as an effective method by which to prevent SSIs through the escalation of the immunological response and the growth of new tissue. This decision analysis aims to answer the clinical question: Should Autologous Platelet Gel be used in Coronary Artery Bypass Grafting procedures along with the current standard of care (SOC)? A decision analytic model was used to determine the total expected mortality that is produced from the use of the standard of care (SOC) alone and the SOC along with APG, giving respect to (a) severity of the SSI; (b) development of deep SSI from a superficial SSI; (c) surgical revision of the SSI; and (d) the cause of mortality.en_US
dc.language.isoen_USen_US
dc.rightsBaylor University projects are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission.en_US
dc.subjectAutologous platelet gel.en_US
dc.subjectPlatelet gel.en_US
dc.subjectPlatelet rich plasma.en_US
dc.subjectFormal decision analysis.en_US
dc.subjectDecision analytics.en_US
dc.subjectDecision theory.en_US
dc.subjectComparative effectiveness.en_US
dc.subjectCoronary artery bypass grafting.en_US
dc.subjectDecision analysis.en_US
dc.subjectCardiovascular surgery.en_US
dc.subjectSurgical site infections.en_US
dc.subjectNosocomial infections.en_US
dc.subjectExpected mortality.en_US
dc.titleComparative Effectiveness of Autologous Platelet Gel in Coronary Artery Bypass Grafting Surgery: A Formal Decision Analysisen_US
dc.typeThesisen_US
dc.rights.accessrightsWorldwide access.en_US
dc.rights.accessrightsAccess changed 12/15/14.
dc.contributor.departmentEconomicsen_US
dc.contributor.schoolshonors collegeen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record